Learning Objective 1: This study provide clinical staff understand the cholangiocarcinoma and its influencing factors in patients with depression.
Learning Objective 2: Important explanatory factor of cholangiocarcinoma in patients with depression as adisease and symptom distress, uncertainty.
.This was a descripitive-correlational cross-sectional study.In this study, the convenience sampling was used. Seventy patients of cholangiocarcinoma was recruited from gastroenterology general surgery, hepatic-biliary-pancreatic- medicine, hematology and oncology inpatient and outpatient department in one northern medical center.
The structured questionnaires including 「demopraphic data 」,「Mishel’s Uncertainty in Illness Scale –Adult :MUIS-Adult)」,「Medical Outcomes Study Social Support Survey : MOS Social Support Survey」,「Beck’s Depression Inventory：BDI-II)」and「symptom distress scale for cholangiocarcinoma patient」.The data were analyzed by SPSS for 18.0 in term of descriptive statistics , Univariate logistic regression analysis and Logistic hierarchical regression analysis.
1. Cholangiocarcinoma in patients with depression average score 16.62 points , 55.7% of patients had depression.
2. Cholangiocarcinoma patients uncertainty in illness was significantly related to depression, Uncertainty in illness are more prone to more severe depression symptoms
3. Cholangiocarcinoma patients symptom distress was significantly related to depression, symptom distress are more prone to more severe depression symptoms
4. Important explanatory factor of cholangiocarcinoma in patients with depression as adisease and symptom distress, uncertainty.When the symptom distress that they have for each 1 score increase in ilness was increased 1.22
time the chance, uncertainty in illness was increased by 1 socre that they have opportunity do depression as 1.66 times.
Results of this study provide clinical staff understand the cholangiocarcinoma and its influencing factors in patients with depression, Hope this study can be used as medical care of these patients clinical reference, to increase the adaptive capacity of patients, thereby reducing depression generated.